View Article

Abstract

High-Performance Liquid Chromatography (HPLC) is presented as a pivotal analytical technique for the qualitative and quantitative assessment of chemical compounds, particularly within pharmaceutical, environmental, clinical, and forensic contexts. The document details HPLC’s operational principles, benefits, and limitations, as well as the distinct types—normal phase, reversed phase, size exclusion, and ion exchange chromatography. Key aspects of instrumentation, including mobile and stationary phases, sample injection, and detection systems, are explained. The process of method development covers considerations for chromatographic conditions, sample preparation, buffer selection, and optimization strategies. Comprehensive coverage of method validation is provided, aligning with international guidelines (ICH, USP, FDA), and including specificity, linearity, precision, accuracy, solution stability, detection limits, robustness, and system suitability. This resource serves as a complete guide for practical implementation and validation of HPLC methods in diverse analytical applications.

Keywords

High performance liquid chromatography (HPLC) , Method Devlopment, Method Validation, Instrumentation, Limit of Detection, Limit of Quantification, (LOD, LOQ ) Application

Introduction

High-performance liquid chromatography (HPLC) stands as a powerful analytical tool in modern chemistry.   It excels at identifying, measuring, and separating components within liquid-dissolved samples.   Widely employed in pharmacological product analysis, HPLC is prized for its precision in both quantitative and qualitative assessments, contributing significantly to advancements in analytical chemistry.(1) High performance liquid chromatography (HPLC), which is widely used for the quantitative and qualitative analysis of drug products as well as for determining drug product stability, is the most precise method of analysis.(2) Compared to gas chromatography, High Performance Liquid Chromatography is more adaptable.(3)

? The technique of HPLC has following features.

  1. Superior resolution
  2. Small diameter, Stainless steel, Glass column
  3. Rapid analysis
  4. comparatively higher pressure in the mobile phase  
  5. controlled mobile phase flow rate.

Principal 

The plan is to inject a sample solution into a porous material column and pump a liquid (the stationary phase) through the column at high pressure. The basis for sample separation is the variation in migration rates through the column resulting from the sample's partitioning into the stationary and mobile phases. At, elution takes place. different times based on how various components behave during partitioning.

ADVANTAGES 

HPLC has numerous advantages over other chromatographic ways. It has made significant donation to  the growth of logical wisdom and its different operation in medicinals, environmental, forensics, foods,  polymers and plastics, clinical fields etc.

  1. For a wide range of grueling samples, HPLC offers an extremely specific, nicely precise, and fairly quick  logical system.  
  2. Macromolecules can be dealt with using the HPLC system.
  3. It's profoundly suitable for utmost ‘ pharmaceutical medicine substances’.  
  4. HPLC allows the reliable analysis of a good number of products, including metabolic, biochemical, and  non- unpredictable substance, polar composites etc.  
  5. The sample's medication and donation are simple in HPLC.  
  6. Both the separation speed and emulsion resolution are high. 8. HPLC software is able of reporting precise  and accurate results.  
  7. The sensors that are used are veritably sensitive.  
  8. HPLC coupled with mass spectrophotometers and FT- IR system have bettered efficacity.

DISADVANTAGES 

  1. Complexity of separation of certain antibodies specific to the protein.
  2. The cost of developing an HPLC apparatus for assay or  method of separation of individual components is  tremendous.
  3. Due to the speed of the HPLC and its reliance on the different polarities; two compounds with similar  structure and polarities can exit the chromatographic apparatus at the same time (coelution). This is difficult in detecting compounds.
  4. a lack of sensitivity to some compounds toward column stationary phase is challenging.
  5. Some compounds are absorbed or react with the chemicals in the column's packing materials.  
  6. The column may not be able to separate or withstand pressures that are either too high or too low at certain points.
  7. Qualitative analysis may be limited unless HPLC is used mass spectrometry as an interface. (4)

? Application 

Identification, quantification, and resolution of compound are all examples of the information that can be gleaned from HPLC. The procedure of isolating and purifying compounds is referred to as preparative HPLC. This is in contrast to analytical HPLC, where information about the sample compound is the primary goal.

Chemical Separation : The foundation of it is because different compounds migrate at different rates in different columns and mobile phases, the choice of stationary phase and mobile phase most often determines the degree of separation.

Purification : The term "purification" refers to the or contaminants, the process of separating the target compound from a mixture of compounds or extracting it showed a distinctive peak for each compound under specific chromatographic conditions. In order for the pure desired compound to be collected or extracted without introducing any other undesirable compound, the migration of the compounds and contaminants through the column must differ sufficiently.

Identification : Typically, HPLC is used to analyze the compounds in the assay. This assay's parameters should be set so that the chromatograph can see a clear peak of the known sample. The identifying peak should have a reasonable retention time and should be well separated from extraneous peaks at the detection levels which the assay will be performed.(5)

Other applications of HPLC : Other applications of HPLC includes

Pharmaceutical applications (6-7)

? Study of how pharmaceutical dosage forms break down.

? Estimates of pharmaceutical dosage forms' shelf lives .

? The active components have been identified.  

? pharmaceutical quality control.

Environmental application (8-9)

? Phenolic compounds found in water for drinking.

? Sedimented samples contained diphenhydramine.  

? Body monitoring of pollutants.

Types of HPLC 

The phase system used determines which High-Performance Liquid Chromatography (HPLC) method is used for analysis. Analytes are categorized according to their polarity using normal phase chromatography (NP-HPLC) or normal phase HPLC. An interaction between a non-polar mobile phase and a polar stationary phase retains polar analytes in NPHPLC. This interaction causes an increase in elution time with increasing polarity of the analyte. NP-HPLC provides effective separation, revealing insights into sample composition based on polarity, making it a valuable analytical tool, particularly in characterizing compounds with different polarities in diverse fields such as chemistry, pharmaceuticals, and environmental analysis.(1)  

  1. Normal Phase chromatography  
  2. Reversed Phase chromatography  
  3. Size exclusive chromatography  
  4. Ion exchange chromatography

Normal Phase chromatography 

In normal phase chromatography, the stationary phase is polar, while the mobile phase is non-polar. As a result, the polar analyte remains in the station phase. Due to a longer elution time, the polarity of solute molecules enhances their ability to adsorb. This is due to the stationary phase's lower affinity for non-polar compounds. The mixture's polar compound is moving through the column. These methods can be used to identify and separate people, but they are rarely used in pharmaceutical applications.(10)

Reversed Phase chromatography 

Utilizing an aqueous, moderately polar mobile phase and a non-polar stationary phase, reversed phase chromatography (RP-HPLC or RPC) phase of inactivity Hydrophobic interactions, which are brought about by repulsive forces exerted by two or more non-polar stationary phase, a relatively non-polar analyte, and polar eluent. The area of contact surrounding the non- polar section of the analyte molecule in the aqueous eluent after association with the ligand is proportional to the analyte's binds to the phase that is stationary.(11)

Size exclusive chromatography 

It separates molecules according to their molecular mass. Largest molecules are eluted first and the smallest molecules last. This method is generally used when a mixture contains compounds with a molecular mass difference of at least 10%. This mode can be further subdivided into gel permeation chromatography (with organic solvents) and gel filtration chromatography (with aqueous solvents).(12)

Ion exchange chromatography 

In exchange of ions retention is based on the attraction in IC chromatography. between charged sites attached to the stationary and solute ions phase. Solute ions with the same charge as the sites that are charged on the column are not bound, but solute ions are. the column's charged sites are of the opposing charge. kept in place on the column. Ions of solute that remain on the By altering the solvent, the column can be eluted from the column. conditions (such as increasing the solvent system's ion effect) by increasing the solution's salt concentration, increasing the solvent's pH, changing the temperature of the column, and so on...) (13)

Instrumentation Of HPLC 

In High-Performance Liquid Chromatography (HPLC), analytical separation involves the high pressure flow of liquid through a stationary phase that can be either liquid (L) or solid (LSC/LLC). Injected compounds separate as they travel through the column, and electronic detection takes place as they clute at the column's end. Even though HPLC is less adaptable than Gas Chromatography, it has a wider range of mobile and stationary phases, making it more useful for precise compound analysis in biochemistry and pharmaceuticals.(14)

Figure No.1 Flow Diagram of HPLC Instrumentation

The parts of the HPLC system are:  

  1. Mixing system, solvent reservoir, and degassing system  
  2. Pump with high pressure  
  3. Sample injector
  4. Column
  5. Detector
  6. Data Recording System                

? Mixing system,solvent reservoir, and  deggasing system 

The solvent is kept in the solvent reservoir, also known as the mobile phase. These are stainless steel or glass containers that do not change color. Glass bottles are the most prevalent type of solvent reservoir Aside from delivering mobile phase, the pump must also combine solvents with extreme accuracy and precision. Mixing at low pressure and high pressure are the two distinct varieties of mixing unit. Air bubbles that have become stuck in the solution are removed by the degassing mechanism. Ultrasonication and filtration are two methods of degassing.(11)

? Pump with high pressure 

A high-pressure pump also known as a solvent delivery system manager is used to generate and meter a specified flow rate of the mobile phase, usually in milliliters per minute The pump forces and suctions the mobile phase into the solvent reservoir it goes to the column and then the detector. The procedure pressure depends on column dimensions, particle size, flow rate and mobile phase's composition. Normal flow rates in The HPLC speeds range from 1 to 2 ml/min Standard pumps can reach pressures between 6000 and 9000 psi (400 and 600 bar).(15)

? Sample Injection 

There are septum injectors; which sample solution should they be used with? is administered. An injector, also known as an autosampler or sample manager, capable of injecting the sample continuously into the mobile phase stream that transports the sample into the Column for HPLC. A brand-new, cutting-edge rotary valve and loop With the injector, you can get results that are repeatable. Typical The sizes of the sample are 5 to 20 microliters (l).(15)

? Column  

HPLC columns are packed with very fine particles (usually a few microns in diameter). To achieve, the extremely fine particles are required. the low dispersion that enables modern plate counts to be high HPLC. It is possible to count more than 25,000 plates per column. with modern columns, however, these very high efficiencies are very rare in actual samples because of the dispersion that comes with data acquisition systems, injection valves, and the dispersion because real samples have a higher molecular weight than the common samples for testing Introducing these minute particles to the column is a challenging technical issue, even with good packing, a great amount of care needs to be taken of the inlet and the fittings at the column ends. and an outlet connection to minimize dispersion.(16)

? Detector  

This is a tool for continuously registering particular chemical or physical properties of the column discharge. The most widely used detector is pharmaceutical analysis is UV (ultraviolet), which allows observing and continuously recording the UV absorbance at a particular wavelength or across a range of wavelengths (the detection by diode arrays). The manner in which the The analyte in the detector flow cell is what alters the absorbance. If the analyte absorbs greater than the a positive signal is obtained from the background (mobile phase).(17)

? Data Recording System 

The outcomes are depicted as a series of high points, and the computer that is connected to the display calculates the space under each high point automatically.(5)

Method Of Development 

Analytical method development and validation play important roles. in the discovery development and manufacture of pharmaceuticals. These methods used to ensure the identity, purity, potency, & performance of drug products. There are many factors to consider when developing methods. The initially collect the information about the analyte's physiochemical properties (pKa, log P. solubility) and determining which mode of detection would be suitable for analysis in case of UV detection.(18-19) The majority of the analytical Validating a stability requires development effort. describing the HPLC method. The purpose of the HPLC method is to quantify the primary active drug separately, any impurities from reactions, as well as any synthetic inter- mediate and any degradants.

The method involves steps. development are:  

  1. calibrated and qualified instrument
  2. outlined procedures
  3. Reliable standards of reference  
  4. specialized analysts  
  5. Integrity and selection of the samples  
  6. The analysis ought to take as little time as possible and should be economical.  
  7. The analyst's accuracy must accept the guidelines of pharmacopoeia.  
  8. The chosen method should be precise and elective.  
  9. Configure the HPLC conditions. 10. Preparation of the method's sample solution development.  
  10. Method optimisation.  
  11. Development and validation of method (20)  

Figure 2. Steps involved in HPLC Method Devlopment  Steps involved in Method Devlopment are (21)

? Knowing the physical and chemical properties of the drug molecule

?Set up of chromatographic condition.

 ?Developing the approach of analysis.  

? Sample preparation  

? Method Optimization   

?  Validation

Knowing the physical and chemical properties of the drug molecule

Physiochemical properties of a drug molecule play an important role in method development. for the method development one has to study the physical properties like solubility, polarity, pKa and pH of the drug molecule. Polarity is a physical property of a compound. It helps an analyst, to decide the solvent and composition of the mobile phase. The solubility of molecules can be explained on the basis of the polarity of molecules. Polar, such as water, and nonpolar, e.g. benzene, solvents do not mix. In general, materials of the same polarity dissolve one another, so soluble in each other. The solubility of the analyte is taken into consideration when selecting a mobile phase or diluent. The chemical must not react with any of its constituents and must be soluble in diluents. pH and pKa play an important role in Method development for HPLC. The negative of the logarithm to base 10 of the pH value is the the amount of the hydrogen ion. [H3O+] = -log10, pH. When an appropriate pH is chosen for ionizable analytes, HPLC frequently exhibits symmetrical and sharp peaks. Sharp, In quantitative analysis, symmetrical peaks are required to attain low relative and low detection limits. reproducible retention times and standard deviations between injections (22-23)

Set up of chromatographic conditions 

A set of initial conditions (detector, column, mobile) were established during the initial method development. phase) is chosen to produce the initial "scouting" chromatograms of the sample. In most instances, On a C18 column equipped with UV detection, reversed phase separations are used. At this point, a It is necessary to choose between developing an isocratic or a gradient method. (24)

Buffer Selection 

The desired pH determines which buffer to use. The typical pH range for reversed phase on silica based packing is pH 2 to 8. Since the buffer must have a pKa that is close to the desired pH, buffer has the highest pKa for pH control. Choosing a buffer with a pKa value less than 2 units of the desired mobile is a rule. pH of a phase.

General considerations for selecting a buffer:  

  1. Phosphate is more soluble in methanol/water than in acetonitrile/water or THF/water.  
  2. Some salt buffers are hygroscopic, which may alter the chromatography and result in more tailing. of basic compounds and possibly differences in selectivity.  
  3. Ammonium salts are generally more soluble in organic/water mobile phases.  
  4. With time, trifluoroacetic acid can degrade. It is volatile and absorbs at low UV wavelengths.  
  5. In buffered mobile phases with little or no organic modifier, microbial growth can occur quickly. The growth accumulates on column inlets and can damage chromatographic performance.  
  6. Phosphate buffer accelerates the dissolution of silica at a pH higher than 7, significantly reducing its lifetime. of HPLC columns based on silica. Organic buffers with a pH greater than 7 should be used whenever possible.
  7. Ammonium bicarbonate buffers usually are prone to pH changes and are usually stable for only 24-48 hours. The pH of this mobile phase tends to become more basic due to to the release of carbon dioxide.  
  8. A 0.2 micrometer filter should be used to filter the buffers after they have been prepared.
  9. Degassing the mobile phase is required.(25)

Buffer Concentration 

Generally, a buffer concentration of 10-50 mM is suitable for use with small molecules. Generally, no morethan 50% organic should be used with a buffer. This will be influenced by the particular buffer and its concentration. Phosphoric acid and its sodium or potassium salts are the most common buffer systems for HPLC in the reversed phase. Buffers sulfonate can replace phosphonate buffers when analyzing organophosphate derivatives.(26)

Buffering Capacity 

Buffering Capacity is the ability of the buffer to resist changes in pH :

  • Buffering Capacity increases as the molar concentration (molarity) of the buffer salt/acid solution increases.
  • The closer the buffered pH is to the pka, the greater the Buffering Capacity.

Buffering Capacity is expressed as the molarity of Sodium Hydroxide required to increase pH by 1.0. Consideration of the affect of pH on analyte retention, type of buffer to use, and its concentration, solubility in the organic modifier and its affect on detection are important in reversed-phase chromatography (RPC) method development of ionic analytes.  An improper choice of buffer, in terms of buffering species, ionic strength and pH, can result in poor or irreproducible retention and tailing in reverse-phase separation of polar and ionizable compounds (27- 28 )

Isocratic and Gradient Separation

Isocratic separation refers to the column's equilibrium conditions and the actual speed at which compounds move through the column are constant.  The peak capacity is low and the longer the component is retained on the column the wider is the  consequent peak. Gradient mode of separation includes increases in the separation power of a system due to an increase of the  apparent efficiency (decrease of the peak width).  The peak of width depends on the rate of the eluent composition variation.  Isocratic's calculated ratio of 0.25 is sufficient. A gradient would be sufficient when the ratio is greater than 0.25. (21)

Detector Selection 

Detector is a very critical component of the HPLC method selection of the detector depends required, the availability and/or the expense of the detector.  UV-Visible detector is a flexible. on the chemical quality of the analytes, the possible disturbance, the detection limit is dualwavelength HPLC absorbance detector.  This detector provides the high sensitivity needed for routine UV-based applications for low-level impurity detection and quantitative analysts The Detector provides superior optical detection for water analytical HPLC, Preparative HPLC, or LC/MS system solutions.  High chromatographic and spectral sensitivity are provided by its integrated software and optics innovations.  This detector is ideal for evaluating components with or without limited UV penetration due to its stability, reproducibility, chromatographic and spectral accuracy, and refractive indexes. The Multiwavelength Fluorescence Detector measures low target chemical concentrations using fluorescence detection with great sensitivity and selectivity. (29 -30)

Column Selection  

The column is at the basis of the HPLC technique.  Changing the column would have the greatest impact on the resolution of analytes during the production of the process.  A successful chromatographic separation and accurate and reliable analysis can be achieved with the right column. Sometimes, an incorrectly used column can cause uncertainty, difficulties, and weak separations that can lead to results that are invalid or difficult to interpret Generally, modern reverse-phase HPLC columns are made by packing column housing with spherical silica gel beads that are coated with a stationary.(31)

Column temperature 

The use of high temperatures can be advantageous for a number of reasons. First, operating at a temperature higher than ambient lowers the viscosity of the mobile phase and, as a result, the total back pressure of the column. Because temperature influences selectivity, temperature control of the column is essential for long-term reproducibility. A target temperature of 30-40 C is typically appropriate for good reproducibility. Lower system pressures allow higher flow speeds and hence faster analysis.  Temperature can also affect selectivity patterns because analytes may react appropriately to different temperatures. (32)

 Selection of Mobile Phase  

The mobile phase effects resolution, selectivity and efficiency.  The mobile phase In RPHPLC separation, composition, also known as solvent strength, plays a significant role. Acetonitrile (ACN),  methanol (MeOH) and tetrahydrofuran (THF) are commonly used solvents in RP-HPLC having low UV cut-off  of 190, 205 and 212nm respectively.  These solvents are miscible with water.  Mixture of acetonitrile and water is  the best option for the mobile phase of method development at the outset. (33)

Developing the approach analysis 

While developing the analytical method on RP-HPLC the first step is followed is the selections of various chromatographic parameters like selection of mobile phase, selection of column, selection of flow rate of mobile phase, selection of pH of mobile phase.  All of these parameters are selected on the basis of trials and followed by considering the system suitability parameters.  Typical parameters of system suitability are e.g. retention time should be more than 5min, the theoretical plates should be more than 2000, the tailing factor should be less than 2, resolution between 2 peaks should be more than 5, % R.S.D of the area of analyte peaks in standard chromatograms should not be more than 2.0% like other.  Detection wavelength is usually isobestic point in the case of simultaneous estimation of 2 components.  After this the linearity of the drug is studied in order to know the range of concentrations up to  which the drug follows the linear pattern.  Analysis of the laboratory mixture is also carried out in order to  the developed method for simultaneous estimation's applicability. After that analysis of marketed formulation is carried out by diluting the marketed formulation up to concentration range of linearity. ( 34-35-36-)

Sample preparation 

The solvent in which the sample is dissolved plays an important role in terms of peak band broadening and retention  time of the solute.  If the sample solvent is different than the mobile phase, one or more distinct system peaks, either  positive or negative, may be obtained.  The best chromatographic result is obtained if sample and dilutions are prepared in mobile phase.  A sample may be difficult to dissolve in the mobile device in some instances due to its lack of solubility. phase.  In such cases, a stronger, i.e., less polar solvent may be used to dissolve the sample.  Utilization of a less polar solvent can cause peak band broadening or distortion and reduction in retention time.  It is important to inject a blank  of the solvent to identify system peaks. (37)

Method Optimization 

Identify the method's "weaknesses" and optimize the method using experimental design.  Understand how the method performs under different conditions, with different instrument  setups, and with different samples.(38)

Validation 

Validation is the systematic process of assessing and providing objective evidence that specific requirements for a particular intended use are met.  It entails assessing a method's effectiveness and demonstrating its capacity to fulfill particular requirements. Essentially, validation provides a thorough understanding of what your technique can reliably produce, particularly when dealing with low doses or challenging conditions in analytical methods like High-Performance Liquid Chromatography (HPLC).(39)

Method Validation 

The methods were validated in conjunction with the International Conference on Harmonization (ICH) recommendations for the validation of analytical methods.  Validation is necessary for any new or updated medication to ensure that it can produce reproducible, consistent, and effective outcomes.  The process by which laboratory experiments have established the method's performance requirements is known as validation of the analytical method. Mest the requirements of the anticipated analytical application. The guidelines of the USP, ICH, FDA, etc. can also provide a basis for validation of pharmaceutical methods.( 40-41)

Scope Of Process Validation 

Validation is one of the broadest and most complicated arcas wanit manufacturing levels.  In various fields, the scope of validity is as follows

  • Analytical
  • Calibration of the Instruments
  • Services for utility   processing  
  • Raw materials
  • Packaging materials
  • Equipment
  • Facilities
  • Manufacturing processes  
  • Product Design
  • Cleaning
  • Operators

Importance stages in validation  Stage 1

This includes the pre-validation qualification stage covering all exercises that define and  improve product studies, pilot batch testing formulation, scale-up analysis, exchange of product studies, Innovation for groups on a market scale, setting the conditions for stability, ln process, completed pharmaceutical formulations, and maintenance of Equipment, master, and process limit approval.(42)

Stage 2

This contains the validation step of the procedure.  Its function is to guarantee that any installed limit of critical process parameter is not exceeded. is significant and that satisfactory products can be  generated even in the most dire circumstances.(42)

Stage 3

It is also known as the validation maintenance stage, and it requires that all archives relating to the procedure, including validation of the review reports, to ensure that The production procedure has not undergone any modifications, failures, or errors, and that all change control procedures in standard operating procedures (SOPs) must be detected.  The approval team, which consists of representatives from each major departments, guarantees that no improvements or deviations have occurred that would require  revalidation and requalification.(42)

Types of process validation 

  • Prospective validation  
  • Concurrent validation  
  • Retrospective validation  
  • Re-validation

Prospective validation 

It is defined as the established, documented evidence that a system performs as intended under predetermined conditions. protocol.  This validation is typically carried out prior to the distribution of a new or previously developed product. changed the way things are made. It was performed on at least three consecutive batches.  Prospective Validation employs the validation protocol is executed before the process is put into commercial distribution of product.  During the product during the development phase, the production procedure ought to be broken down into distinct steps. Each step should be  evaluated on the basis of experience or theoretical considerations to determine the critical parameters that may affect  the quality of the finished product.(43)

Concurrent validation 

End-product output current testing and in-process tracking of essential processing steps may provide documented evidence that the manufacturing process is under control. Except for the fact that the operating entity will sell the product during the qualification runs, it will be sold to the general public at a price that is comparable to the market price.(44)

Retrospective validation 

Such processes can be validated with historical evidence. The steps involved include creating a specific protocol and publishing the data review's findings, which lead to a conclusion and a recommendation. Retrospective validity is based on the requirement that true in-process requirements for those characteristics be compatible with the drug product's final product requirements.(45)

  • Batch size/strength/producer/year/period.
  • File masters for production and packaging.
  • Current particulars for active ingredients/finished materials. (46)

Re-Validation

It is a validated phase or element that has been reproduced.  Changes of the source of the active raw material producer are among the changes in re validation.(46)

  • changes made to crude materials.  
  • changes made to the active crude material producer's source.
  • Alteration of packing material
  • Modifications inside the plant/facility.(46)

Validation Parameters  

The following are typical parameters recommended by the FDA, USP, and ICH.  

  1. Specificity  
  2. Linearity & Range  
  3. Precision  

I.  precision of the method (repeatability) II.  Intermediate precision (Reproducibility)  

  1. Accuracy (Recovery)  
  2. Solution stability  
  3. Limit of Detection (LOD)
  4. Limit of Quantification (LOQ)
  5. Robustness
  6. Range  
  7. Suitability of the System (24)

Specificity

In strategy approval, selectivity and specificity are sometimes used interchangeably to  represent the same concept.  Specificity is the ability to evaluate the analyte unequivocally in  the vicinity of components that might need to be shown. A test system's specificity is controlled by contrasting test results obtained from an investigation of tests containing  contaminations, debasement products, or placebos with substances obtained from an investigation of tests without contaminations, debasement items, or placebo fixings.(47-48)

Linearity and Range 

Linearity in an analytical process refers to its ability to produce test results that are directly proportional to the concentration of the analyte in the sample, within a specified range.  It is crucial to evaluate this linear relationship, across the spectrum of the analytical technique.  The suggested approach involves diluting a normal stock solution containing the constituent parts of the medicinal product to directly demonstrate linearity on the drug substance.

The range of an analytical method is defined as the interval between the higher and lower values that have been demonstrated to be determined with precision, accuracy, and linearity using the method. ICH recommendations recommend a minimum of five concentrations for establishing linearity. The confidence interval around the slope of the regression line is commonly used to establish linearity. Over a predetermined concentration range, this comprehensive evaluation guarantees the analytical method's validity and reliability.(24)

Precision 

The degree of consistency between the individual test results obtained by applying the method to repeated sampling of a homogeneous population trail determines an analytical method's precision. The reproducibility of the entire analytical process is measured by precision. It is divided into two sections. Repeatability and intermediate precision.(49)

Accuracy

The accuracy of a measurement is defined as the closeness of the measured value to the true value.  In a method with high accuracy, a sample (whose “true value” is known), the measured value is analyzed, and identical to the true value.  Typically, accuracy is represented and determined by recovery studies.   

There are three ways to assess accuracy:  

  1. Comparison to a reference standard.
  2. The analyte was recovered and spiked into a blank matrix.
  3. The analyte is added as usual.  
  4. It should be clear how the individual or total impurities are to be determined.(50)

Solution Stability 

During normal validation, the stability of standards and samples is established. conditions, typical conditions of storage, and occasionally in the instrument to determine whether Requirements for special storage conditions include light protection or refrigeration. (24)

Limit of Detection (LOD)

The most fundamental measure of an analyte in a sample that can be identified but cannot be accurately quantified is the detection limit of a single analytical method. A fundamental indicator of the method's sensitivity is this limit, which represents the lowest concentration at which the analyte can be reliably detected.(51)

Limit of Quantification (LOQ)

The limit of Quantitation (LOQ) or Quantitation limit  of a specific analytical method is the lowest amount of analyte that can be found in a sample quantitatively determined with suitable precision and  accuracy.  

 For analytical procedures such as HPLC that exhibit baseline noise, and the LOQ is typically calculated using most of the time, the LOQ is estimated because of baseline noise. from a determination of S/N ratio (10:1) and is  typically verified by injecting standards that provide this ratio of S/N and a respectable percentage of also the standard deviation. (52-53)

Robustness 

The robustness of an analytical procedure is a  measure of its inability to be influenced by small, but deliberate variations in method parameters and provides an indication of its reliability  during regular use. The variable method parameters in HPLC technique may include flow rate, pH, sample temperature, and column temperature mobile phase structure. (54- 55)

Range 

The range of an analytical method refers to the interval between the higher and lower values of an analyte that have been demonstrated with sufficient linearity. precision, and accuracy.  This range is typically determined based on a linear or nonlinear response curve and is expressed in the same units as the test findings.  To accurately evaluate and report results within the method's validated and reliable concentration limits, it is necessary to establish a defined range.(56-57)

Figure 3. Range determination  10. Suitability of System

Liquid chromatographic methods include system suitability tests as a standard procedure.  They are utilized to guarantee that the resolution, detection sensitivity, and for the analysis, and reproducibility are adequate. The tests are predicated on the concept that Analytical procedures, equipment,and samples to be analyzed are all components of a that can be evaluated as a whole as a whole. To determine the suitability of the used method,  aspects like peak resolution, theoretical plate count, peak tailing, and capacity were measured. (56)

CONCLUSION -: HPLC is a gold standard analytical technique offering precise, reproducible results for the identification, purification, and quantification of diverse compounds. Its effectiveness, however, depends on rigorous method development, validation, and optimization tailored to the specific context and sample matrix. For best results, continual monitoring of instrument performance and strict adherence to international validation guidelines are essential. The document provides a comprehensive reference for both practical implementation and theoretical understanding of HPLC, highlighting its central role in modern chemical analysis alongside recommendations for mitigating its technical challenges.

REFERENCES

  1. Mehta DK. HPLC method development and validation. World J Pharm Med Res. 2024;10(C1):233-41. 
  2. Rao BV, Bowjanya GN, Ajitha A, Rao VU. A stability-indicating HPLC method development. World J Pharm Pharm Sci. 2015;4:405-28. 
  3. Khandagale SS, Madhut M, Pawar R, Kothare NS. HPLC method development and validation. International Journal of Progressive Research in Engineering Management and Science. 2024;4:2336-9.
  4. Sudev S, Jahardhana SV. Review on HPLC method development, validation and optimization. International Journal of Pharmacy Science Review. 2019;56(2):28-43.
  5. Malviya R, Bansal V, Sharma P.High-performance liquid chromatography: a short review. Journal of Global Pharma Technology. 2010;2(5):22-6.
  6. Bergh JJ, Breytenbach JC. Stability-indicating high-performance liquid chromatographic analysis of trimethoprim in pharmaceuticals. J Chromatogr. 1987;387:528-31.
  7. Bounine JP, Tardif B, Beltran P, Nuzzo DJ.High-performance liquid chromatographic stability-indicating determination of zopiclone in tablets. J Chromatogr. 1994;677(1):87-93.
  8. Lauback RG, Rice JJ, Bleiberg B, Muhammad N, Hanna SA. Specific high-performance liquid chromatographic determination of ampicillin in bulk, injectables, capsules, and oral suspension by reversed-phase ion-pair chromatography. J Liq Chromatogr. 1984;7(6):123465.
  9. Yu H, Jing C, Shang H, Jin D. Application of toxicity identification evaluation procedure on wastewater and sludge from a municipal sewage treatment works with industrial inputs. Ecotoxicology and Environmental Safety.2004;57(3):426-30.
  10. Varma MM, Thullura A, Sunil Kumar KT, Sal Kumar G, Pavani K. HPLC method development and validation: a review. World Journal of Pharmaceutical Research. 2021;10:405-26.
  11. Varma MM, Thullura A, Sunil Kumar KT, Sal Kumar G, Pavani K. HPLC method development and validation: a review. World Journal of Pharmaceutical Research. 2021;10:405-26..
  12. Azim MS, Molay M, Bhasin PS. HPLC method development and validation: a review. Int Res J Pharm. 2013;4(4):39-46.
  13. Ali AH. High performance liquid chromatography (HPLC): a review. Anal Adv Chem. 2022;6:10-20.
  14. Dong MW. Modern HPLC for practicing scientists. 1st ed. Hoboken (NJ): John Wiley & Sons; 2006. 120-135.
  15. Chawla G, Chaudhary KK. A review of HPLC technique covering its pharmaceutical, environmental, forensic, clinical and other applications. Int J Pharm Chem Anal.2019;6(2):27-39.
  16. Jena AK. HPLC: Highly Accessible Instrument in Pharmaceutical Industry for Effective Method Development. Pharm Anal Acta. 2011;3(1):147.
  17. Taleuzzaman M, Ahmed MM, Chattopadhyay M. Particle size role, importance and strategy of HPLC analysis - an update. Int Arch BioMed Clin Res. 2016;2(2):5-11.
  18. United States Pharmacopeia and National Formulary (USP 24-NF 19). Asian ed.Rockville (MD): United States Pharmacopeial Convention Inc; 2000. 2126.
  19. Sankar S. Textbook of pharmaceutical analysis. 5th ed. Tirunelveli: Rx Publications; 2006. 23-12.
  20. Kalamkar T, Kande T, Sayad N, Dipti. Analytical method development by high performance liquid chromatography. Int J Trend Sci Res Dev. 2022;6(4):1425-1432.
  21. Giri PT, Mahe SS. Development and validation of HPLC method. Int J Creative Res Thoughts. 2022 Feb;10(2):123-130.
  22. http://www.scribd.com/doc/9508765/Physical-Properties-of-Drug.
  23. Buffers and pH Buffers: available from: www.xtremepapers.com.
  24. Deshmukh PM, Charde MS, Chakole RD. A review on the HPLC method development and validation. Int J Pharm Pharm Res. 2021;21(4):120-130.
  25. Sabir AM, Molony M, Parminder SB. HPLC method development and validation: a review.Int J Pharm. 2013;4(4):39-46.
  26. Shinde M, Kumar S, Malik A, Jyoti N. A review on HPLC method development and validation.EPRA Int J Res Dev. 2021;6(10):100-107.
  27. Reversed phase HPLC buffers: high quality buffer (solution, solid or concentration).[Internet]. Pittsburgh (PA): Center for Chemical Characterization, University of Pittsburgh; [cited 2013 Apr 5]. Available from:https://ccc.chem.pitt.edu/wipf/web/HPLCRP -buffers.pdf.
  28. Wen C. Designing HPLC methods for stability indication and forced degradation samples for API. [Internet]. American Pharmaceutical Review. [cited 2013 Apr 5]. Available from: http://www.americanpharmaceuticalreview.com.
  29. Lindholm J. Development and validation of HPLC methods for analytical and preparative purposes. Acta Universitatis Upsaliensis. 2004;13-14.
  30. Snyder LR, Kirkland JJ, Glajch JL. Practical HPLC method development. 2nd ed. New York: John Wiley & Sons; 1997. p. 233-2910% doi:10.1002/9781118592014.
  31. Pratap B, Rao GHS, Devdas G, Dey A, Harikrishn N. Review on stability-indicating HPLC method development. Int J Innov Pharm Res. 2013;3(3):229-237.
  32. Sowjanya P, Subashini D, Rakesh S. A review on method development and validation by HPLC. RRJPPS. 2015;4(1):17-23.
  33. Pratap B, et al. Importance of RP-HPLC in analytical method development: a review. Int J Novel Trends Pharm Sci. 2013;3(1):15-23.
  34. Sethi PS. Introduction to high performance liquid chromatography. 1st ed. New Delhi: CBS Publishers; 2011. p. 1-28.
  35. Julia T, Mena AJ, Aucoin MG, Kamen AA.Development and validation of an HPLC method for the quantification of baculovirus particles. J Chromatogr B. 2011;879(1):61-68.
  36. Kande TR. Development and validation of an analytical method for simultaneous estimation of pioglitazone and glimepiride by RP-HPLC method. Int J Pharm Sci Rev Res. 2020;61(1):45-51.
  37. Joel K, Swadesh. HPLC: practical and industrial applications. 2nd ed. Boca Raton (FL): CRC Press; 2000. p. 153.
  38. Kayode J, Adebayo. Effective HPLC method development. J Health Med Nurs. 2015;12:123-133.
  39. Higuchi T, Brochmann-Hansen E.Pharmaceutical analysis. 3rd ed. New Delhi CBS Publishers and Distributors; 2007. p. 615.
  40. Sambherao AB, Bhairau BA, Saudagar RB.Analytical method development and validation by RP-HPLC and UV spectrophotometric methods. Eur J Biomed Pharm Sci. 2017;4(10):1-6.
  41. Breaux J, Jones K, Boulas P. Understanding and implementing efficient analytical method development and validation. Pharm Technol Anal Chem Test. 2003;5:6-13.
  42. Jatto E, Okhamafe AO. An overview of pharmaceutical validation and process control in drug development. Trop J Pharm Res. 2002;1(1):15-22.
  43. Rao G, Goyal A. An overview on analytical method development and validation by using HPLC. Chem Pharm J. 2016;3(2):280-289.
  44. Ahir KB, Singh KD, Yadav SP, Patel HS, Poyahari CB. Overview of validation and basic concepts of process validation. Sch Acad J Pharm. 2014;3:78-90.
  45. Nandhakumar L, Dharmamoorthy G, Rameshkumar S, Chandrasekaran S. An overview of pharmaceutical validation and quality assurance viewpoint. Int J Res Pharm Chem. 2011;1:1003-1014.
  46. Nevado JJB, Behal. Reliable and sensitive SPE-HPLC-DAD screening of endocrine disruptors atrazine, simazine and their major multiresidues in natural surface water: analytical validation and robustness study performance. J Chromatogr Sep Tech. 2014;5:215.
  47. Nia Y, et al. Determination of Ti from TiO? nanoparticles in biological materials by different ICP-MS instruments: method validation and applications. J Mahomed Nanotechnol. 2015;6:269.
  48. Nayudu ST, Suresh PV. Bio-analytical method validation: a review. Int J Pharm Chem Res. 2017;3:283- 293.
  49. Kour G, Daksh S. A review on step-by-step analytical method validation. World J Pharm Life Sci. 2018;4(6):39-48.
  50. Ravisankar P, Rajyalakshmi G, Devadas CH, Devala Rao G. Instant tips for right and effective approach to solve HPLC troubleshooting. J Chem Pharm Sci. 2014;7(3):259-274.
  51. International Conference on Harmonisation (ICH). Validation of analytical procedures: text and methodology Q2(R1). Geneva: ICH; 2005.
  52. United States Pharmacopeia (USP). Validation of compendial procedures. In: USP-NF 27(2). Rockville (MD): United States Pharmacopeial Convention; 2010.
  53. Boulanger B, Chiap P, Dewe W, Crommen J, Hubert P. An analysis of the SFSTP guide on validation of chromatographic bioanalytical methods: progress and limitations. J Pharm Biomed Anal. 2003;32:753-765.
  54. Christian GD. Analytical chemistry. 6th ed. Hoboken (NJ): John Wiley & Sons Inc; 2001.
  55. Carr GP, Wahlich JC. A practical approach to method validation in pharmaceutical analysis. J Pharm Biomed Anal. 1990;8:613-618.
  56. United States Pharmacopeia (USP) 24, National Formulary 19. Validation of compendial methods. Rockville (MD): United States Pharmacopeial Convention; 2000. Also referenced in: ICH Q2(R1), Validation of analytical procedures: text and methodology. Geneva: ICH; 2005.

Reference

  1. Mehta DK. HPLC method development and validation. World J Pharm Med Res. 2024;10(C1):233-41. 
  2. Rao BV, Bowjanya GN, Ajitha A, Rao VU. A stability-indicating HPLC method development. World J Pharm Pharm Sci. 2015;4:405-28. 
  3. Khandagale SS, Madhut M, Pawar R, Kothare NS. HPLC method development and validation. International Journal of Progressive Research in Engineering Management and Science. 2024;4:2336-9.
  4. Sudev S, Jahardhana SV. Review on HPLC method development, validation and optimization. International Journal of Pharmacy Science Review. 2019;56(2):28-43.
  5. Malviya R, Bansal V, Sharma P.High-performance liquid chromatography: a short review. Journal of Global Pharma Technology. 2010;2(5):22-6.
  6. Bergh JJ, Breytenbach JC. Stability-indicating high-performance liquid chromatographic analysis of trimethoprim in pharmaceuticals. J Chromatogr. 1987;387:528-31.
  7. Bounine JP, Tardif B, Beltran P, Nuzzo DJ.High-performance liquid chromatographic stability-indicating determination of zopiclone in tablets. J Chromatogr. 1994;677(1):87-93.
  8. Lauback RG, Rice JJ, Bleiberg B, Muhammad N, Hanna SA. Specific high-performance liquid chromatographic determination of ampicillin in bulk, injectables, capsules, and oral suspension by reversed-phase ion-pair chromatography. J Liq Chromatogr. 1984;7(6):123465.
  9. Yu H, Jing C, Shang H, Jin D. Application of toxicity identification evaluation procedure on wastewater and sludge from a municipal sewage treatment works with industrial inputs. Ecotoxicology and Environmental Safety.2004;57(3):426-30.
  10. Varma MM, Thullura A, Sunil Kumar KT, Sal Kumar G, Pavani K. HPLC method development and validation: a review. World Journal of Pharmaceutical Research. 2021;10:405-26.
  11. Varma MM, Thullura A, Sunil Kumar KT, Sal Kumar G, Pavani K. HPLC method development and validation: a review. World Journal of Pharmaceutical Research. 2021;10:405-26..
  12. Azim MS, Molay M, Bhasin PS. HPLC method development and validation: a review. Int Res J Pharm. 2013;4(4):39-46.
  13. Ali AH. High performance liquid chromatography (HPLC): a review. Anal Adv Chem. 2022;6:10-20.
  14. Dong MW. Modern HPLC for practicing scientists. 1st ed. Hoboken (NJ): John Wiley & Sons; 2006. 120-135.
  15. Chawla G, Chaudhary KK. A review of HPLC technique covering its pharmaceutical, environmental, forensic, clinical and other applications. Int J Pharm Chem Anal.2019;6(2):27-39.
  16. Jena AK. HPLC: Highly Accessible Instrument in Pharmaceutical Industry for Effective Method Development. Pharm Anal Acta. 2011;3(1):147.
  17. Taleuzzaman M, Ahmed MM, Chattopadhyay M. Particle size role, importance and strategy of HPLC analysis - an update. Int Arch BioMed Clin Res. 2016;2(2):5-11.
  18. United States Pharmacopeia and National Formulary (USP 24-NF 19). Asian ed.Rockville (MD): United States Pharmacopeial Convention Inc; 2000. 2126.
  19. Sankar S. Textbook of pharmaceutical analysis. 5th ed. Tirunelveli: Rx Publications; 2006. 23-12.
  20. Kalamkar T, Kande T, Sayad N, Dipti. Analytical method development by high performance liquid chromatography. Int J Trend Sci Res Dev. 2022;6(4):1425-1432.
  21. Giri PT, Mahe SS. Development and validation of HPLC method. Int J Creative Res Thoughts. 2022 Feb;10(2):123-130.
  22. http://www.scribd.com/doc/9508765/Physical-Properties-of-Drug.
  23. Buffers and pH Buffers: available from: www.xtremepapers.com.
  24. Deshmukh PM, Charde MS, Chakole RD. A review on the HPLC method development and validation. Int J Pharm Pharm Res. 2021;21(4):120-130.
  25. Sabir AM, Molony M, Parminder SB. HPLC method development and validation: a review.Int J Pharm. 2013;4(4):39-46.
  26. Shinde M, Kumar S, Malik A, Jyoti N. A review on HPLC method development and validation.EPRA Int J Res Dev. 2021;6(10):100-107.
  27. Reversed phase HPLC buffers: high quality buffer (solution, solid or concentration).[Internet]. Pittsburgh (PA): Center for Chemical Characterization, University of Pittsburgh; [cited 2013 Apr 5]. Available from:https://ccc.chem.pitt.edu/wipf/web/HPLCRP -buffers.pdf.
  28. Wen C. Designing HPLC methods for stability indication and forced degradation samples for API. [Internet]. American Pharmaceutical Review. [cited 2013 Apr 5]. Available from: http://www.americanpharmaceuticalreview.com.
  29. Lindholm J. Development and validation of HPLC methods for analytical and preparative purposes. Acta Universitatis Upsaliensis. 2004;13-14.
  30. Snyder LR, Kirkland JJ, Glajch JL. Practical HPLC method development. 2nd ed. New York: John Wiley & Sons; 1997. p. 233-2910% doi:10.1002/9781118592014.
  31. Pratap B, Rao GHS, Devdas G, Dey A, Harikrishn N. Review on stability-indicating HPLC method development. Int J Innov Pharm Res. 2013;3(3):229-237.
  32. Sowjanya P, Subashini D, Rakesh S. A review on method development and validation by HPLC. RRJPPS. 2015;4(1):17-23.
  33. Pratap B, et al. Importance of RP-HPLC in analytical method development: a review. Int J Novel Trends Pharm Sci. 2013;3(1):15-23.
  34. Sethi PS. Introduction to high performance liquid chromatography. 1st ed. New Delhi: CBS Publishers; 2011. p. 1-28.
  35. Julia T, Mena AJ, Aucoin MG, Kamen AA.Development and validation of an HPLC method for the quantification of baculovirus particles. J Chromatogr B. 2011;879(1):61-68.
  36. Kande TR. Development and validation of an analytical method for simultaneous estimation of pioglitazone and glimepiride by RP-HPLC method. Int J Pharm Sci Rev Res. 2020;61(1):45-51.
  37. Joel K, Swadesh. HPLC: practical and industrial applications. 2nd ed. Boca Raton (FL): CRC Press; 2000. p. 153.
  38. Kayode J, Adebayo. Effective HPLC method development. J Health Med Nurs. 2015;12:123-133.
  39. Higuchi T, Brochmann-Hansen E.Pharmaceutical analysis. 3rd ed. New Delhi CBS Publishers and Distributors; 2007. p. 615.
  40. Sambherao AB, Bhairau BA, Saudagar RB.Analytical method development and validation by RP-HPLC and UV spectrophotometric methods. Eur J Biomed Pharm Sci. 2017;4(10):1-6.
  41. Breaux J, Jones K, Boulas P. Understanding and implementing efficient analytical method development and validation. Pharm Technol Anal Chem Test. 2003;5:6-13.
  42. Jatto E, Okhamafe AO. An overview of pharmaceutical validation and process control in drug development. Trop J Pharm Res. 2002;1(1):15-22.
  43. Rao G, Goyal A. An overview on analytical method development and validation by using HPLC. Chem Pharm J. 2016;3(2):280-289.
  44. Ahir KB, Singh KD, Yadav SP, Patel HS, Poyahari CB. Overview of validation and basic concepts of process validation. Sch Acad J Pharm. 2014;3:78-90.
  45. Nandhakumar L, Dharmamoorthy G, Rameshkumar S, Chandrasekaran S. An overview of pharmaceutical validation and quality assurance viewpoint. Int J Res Pharm Chem. 2011;1:1003-1014.
  46. Nevado JJB, Behal. Reliable and sensitive SPE-HPLC-DAD screening of endocrine disruptors atrazine, simazine and their major multiresidues in natural surface water: analytical validation and robustness study performance. J Chromatogr Sep Tech. 2014;5:215.
  47. Nia Y, et al. Determination of Ti from TiO? nanoparticles in biological materials by different ICP-MS instruments: method validation and applications. J Mahomed Nanotechnol. 2015;6:269.
  48. Nayudu ST, Suresh PV. Bio-analytical method validation: a review. Int J Pharm Chem Res. 2017;3:283- 293.
  49. Kour G, Daksh S. A review on step-by-step analytical method validation. World J Pharm Life Sci. 2018;4(6):39-48.
  50. Ravisankar P, Rajyalakshmi G, Devadas CH, Devala Rao G. Instant tips for right and effective approach to solve HPLC troubleshooting. J Chem Pharm Sci. 2014;7(3):259-274.
  51. International Conference on Harmonisation (ICH). Validation of analytical procedures: text and methodology Q2(R1). Geneva: ICH; 2005.
  52. United States Pharmacopeia (USP). Validation of compendial procedures. In: USP-NF 27(2). Rockville (MD): United States Pharmacopeial Convention; 2010.
  53. Boulanger B, Chiap P, Dewe W, Crommen J, Hubert P. An analysis of the SFSTP guide on validation of chromatographic bioanalytical methods: progress and limitations. J Pharm Biomed Anal. 2003;32:753-765.
  54. Christian GD. Analytical chemistry. 6th ed. Hoboken (NJ): John Wiley & Sons Inc; 2001.
  55. Carr GP, Wahlich JC. A practical approach to method validation in pharmaceutical analysis. J Pharm Biomed Anal. 1990;8:613-618.
  56. United States Pharmacopeia (USP) 24, National Formulary 19. Validation of compendial methods. Rockville (MD): United States Pharmacopeial Convention; 2000. Also referenced in: ICH Q2(R1), Validation of analytical procedures: text and methodology. Geneva: ICH; 2005.

Photo
Gayatri Jadhav
Corresponding author

Pharmaceutical Chemistry, Dr. Naikwadi College of D Pharmacy, Jamgaon, Sinnar.

Photo
Monali Khatke
Co-author

Pharmaceutical Chemistry, Dr. Naikwadi College of D Pharmacy, Jamgaon, Sinnar.

Photo
Aarti Nanhe
Co-author

Pharmaceutical Chemistry, Dr. Naikwadi College of D Pharmacy, Jamgaon, Sinnar.

Gayatri Jadhav*, Monali Khatke, Aarti Nanhe, An Overview HAPL Method Development and Validation, Int. J. of Pharm. Sci., 2025, Vol 3, Issue 11, 2945-2962 https://doi.org/10.5281/zenodo.17650743

More related articles
A Review by Paediatric Epilepsy: A Comprehensive O...
Sangram Nagargoje, Pratiksha Pawar, Vaishnavi Rodge, ...
Analytical Method Validation for Heavy Metal Detec...
Mangeshkumar Lilhare, Jagruti B. Shiwankar, Jugnoo S. Chaudhari, ...
An Overview of Synergistic Effect of Anti-Inflamma...
Rupali Joshi, Shruti Dhere, Abhijeet Dhage, Sarthak Dhumal, Komal...
Role of Artificial Intelligence in Drug Discovery and Development: A Pharmaceuti...
Tanvi Sarode, Trupti Mate, Ajay Bhagwat, Sarita Kawad, Swapnil Auti, ...
Design and Development of Clinical Trials...
Sakshi Kengar, Dr. Sanjay Bias, Dr. Savita Sonawane, ...
Related Articles
Review on Method Development and Validation of Diclofenac Sodium Using Different...
Lavanya N., Sujatha P. Muchalambe, Likith Kumar K. B., Mamatha T., Mani Sai Santhoshi, Revanth S., K...
A Review on Study and Overview of Cosmeceutical Products...
Dnyaneshwar Ghuge, Datta Korde , Pawan Hanute , Rushi Throat, ...
Development Of Nirmatrelvir and Ritonavir Simultaneous Estimation Method Using Q...
Prapti Gawand , Reshma Jadhav, Ashish Jain, Priya Jagtap, Bhavesh Mahajan, Prathamesh Chaudhari, Ais...
A Review by Paediatric Epilepsy: A Comprehensive Overview of Diagnosis, Treatmen...
Sangram Nagargoje, Pratiksha Pawar, Vaishnavi Rodge, ...
More related articles
A Review by Paediatric Epilepsy: A Comprehensive Overview of Diagnosis, Treatmen...
Sangram Nagargoje, Pratiksha Pawar, Vaishnavi Rodge, ...
Analytical Method Validation for Heavy Metal Detection in Commercially Available...
Mangeshkumar Lilhare, Jagruti B. Shiwankar, Jugnoo S. Chaudhari, Sindhu B. Wairagade, Swati D. Katre...
An Overview of Synergistic Effect of Anti-Inflammatory Activity Shown by Moringa...
Rupali Joshi, Shruti Dhere, Abhijeet Dhage, Sarthak Dhumal, Komal Dhakane, ...
A Review by Paediatric Epilepsy: A Comprehensive Overview of Diagnosis, Treatmen...
Sangram Nagargoje, Pratiksha Pawar, Vaishnavi Rodge, ...
Analytical Method Validation for Heavy Metal Detection in Commercially Available...
Mangeshkumar Lilhare, Jagruti B. Shiwankar, Jugnoo S. Chaudhari, Sindhu B. Wairagade, Swati D. Katre...
An Overview of Synergistic Effect of Anti-Inflammatory Activity Shown by Moringa...
Rupali Joshi, Shruti Dhere, Abhijeet Dhage, Sarthak Dhumal, Komal Dhakane, ...